Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial
- Resource Type
- Article
- Source
- The Lancet; November 2017, Vol. 390 Issue: 10109 p2266-2277, 12p
- Subject
- Language
- ISSN
- 01406736; 1474547X